Mérieux Equity Partners and Korys announce the launch of OMX Europe Venture Fund, dedicated to Venture investment within the healthcare and nutrition sectors
The new investment platform in Venture Capital will support innovative companies in the healthcare and nutrition sectors, in Europe and North America.
L'Entreprise des Possibles is Mobilizing Businesses to help the homeless in Lyon
First results and sollicitating sponsorships, partnerships and donations.
Nutragroup is fully mobilized to first guarantee the safety and health of its employees, but also to contribute to supporting and enhancing the Health of the Human Beings against the Covid-19 threat
Nutragroup will keep delivering particular vitamins and immuno-stimulants to their customers (Food Supplement laboratories).
Seqens is fully mobilized to guarantee the safety and health of its employees and also to contribute to supporting the Healthcare systems in the Covid-19 battle
Seqens will keep providing active ingredients and pharmaceutical intermediates such as paracetamol and keep developing antivirals and disinfecting solutions.
CEVA Santé Animale returns to strong double-digit growth in 2019 and reveals plans to double sales by 2025
Consolidated sales of the Ceva Group reached more than €1.2 billion in 2019.
Ceva Santé Animale reorganizes its shareholding structure, welcoming new long-term partners alongside existing investors
Twist Bioscience Selected as DNA Synthesis Provider for DNA Data Storage Project Under Intelligence Advanced Research Projects Activity (IARPA) Molecular Information Storage (MIST) Program
Twist Bioscience Promotes Patrick Weiss to Chief Operating Officer
Twist Bioscience also announces the appointment of Bill Banyai, Ph.D., as Senior Vice President of Advanced Development and General Manager of Data Storage.
MERIEUX EQUITY PARTNERS SUCCESSFULLY COMPLETES THE FUNDRAISING OF MERIEUX PARTICIPATIONS 3
Mérieux Equity Partners announces the closing of the fundraising for Mérieux Participations 3, new investment fund dedicated to Growth Capital and Buy-Out within the Healthcare and Nutrition sectors, oversubscribed at € 377 million.